Minimally Invasive Mitral Valve Repair Proves Effective for Patients with High-Risk Tissue Calcification

The EXPANDed study confirms M-TEER reduces valve leakage and improves quality of life for high-risk patients with calcified heart valves.

By: AXL Media

Published: Apr 25, 2026, 9:09 AM EDT

Source: Information for this report was sourced from EurekAlert!

Minimally Invasive Mitral Valve Repair Proves Effective for Patients with High-Risk Tissue Calcification - article image
Minimally Invasive Mitral Valve Repair Proves Effective for Patients with High-Risk Tissue Calcification - article image

Expanding Treatment Horizons for Complex Mitral Valve Disease

New clinical findings presented at the SCAI 2026 Scientific Sessions in Montreal have provided much-needed clarity on the effectiveness of minimally invasive heart valve repair for a historically difficult-to-treat patient group. The research focused on those with mitral annular calcification, a condition where calcium deposits form on the ring of tissue supporting the mitral valve. While this buildup frequently complicates surgical interventions, the latest data suggests that transcatheter edge-to-edge repair remains a safe and effective pathway for reducing mitral regurgitation and restoring cardiac function.

Understanding the Challenges of Calcified Cardiac Structures

Mitral annular calcification often acts as a significant barrier to standard heart treatments, as the rigid calcium deposits can prevent the valve from closing properly. This malfunction leads to symptomatic mitral regurgitation, causing blood to flow backward into the heart and triggering symptoms like fatigue and shortness of breath. For patients deemed too high-risk for traditional open-heart surgery, the M-TEER procedure offers a less invasive alternative by using a small medical clip to join the valve leaflets, ensuring a tighter seal and more efficient blood flow.

Global Scope and Methodology of the EXPANDed Analysis

The research team performed an extensive sub-analysis of the EXPAND and EXPAND G4 studies, drawing from data collected at 91 sites across the United States, Europe, Canada, Japan, and the Middle East. Of the 1,907 participants treated between 2018 and 2022, 327 were identified as having mitral annular calcification. This specific subgroup was characterized by higher surgical risk factors, an older average age, and a higher prevalence of primary mitral regurgitation, with half of the participants in the study having been hospitalized for heart failure within the year prior to the procedure.

Categories

Topics

Related Coverage